N.41
Pre-clinical- Indications
- HIV infection
Company intelligence / Profile preview
Diatheva develops, manufactures, and markets innovative products such as antibodies, recombinant proteins, immunoassays, and SNP detection kits. The company serves research labs and diagnostic markets in cancer biology, infectious diseases (including HIV), pharmacogenetics/personalized medicine. It operates an EMA-authorized GMP facility supporting production of APIs for preclinical to Phase I/II studies. Diatheva also provides custom antibody services and contract development/manufacturing services for biopharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diatheva.